Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Avelumab + talazoparib Phase 2 study (Japan)
jRCT2080224815Phase 2Completed
- Start
- Jul 2019
- Modality
- Immune Checkpoint Inhibitors → Monoclonal Antibodies → Antibody-Based Therapeutics, Recombinant Proteins and Enzymes, Small Molecules
01
Overview
Phase 2, single-arm trial of avelumab and talazoparib in cancer. Started Jul 2019; status: completed.
02
Drugs
avelumabtalazoparib
03
Conditions
cancer
Beyond the preview
Go deeper on jRCT2080224815.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on jRCT2080224815.